The Talent Gap in Biotech: Why Your Next Hire Shouldn’t Be a Hire
In the early stages of a biotech startup, the burn rate isn't just a financial metric; it’s a clock ticking toward your next major milestone. Every decision is filtered through a single lens: Does this get us to our data faster?
When it comes to human capital, many founders feel forced into a binary choice:
The Over-Hire: Bringing on a full-time, C-suite or VP-level veteran. They have the expertise, but they come with a massive salary, equity requirements, and benefits. Often before the company has the daily workload to justify the role.
The Under-Hire: Bringing on a junior scientist or manager to save on overhead. While cost-effective, the learning tax is high. Mistakes in assay design or oversights can lead to months of lost time and wasted capital.
The Third Way: The Fractional Revolution
At Pointer Bio, we believe the talent gap in biotech is actually a timing gap. You need $250k-a-year wisdom, but you might only need it for 10 hours a week.
Hiring a full-time employee is a long-term commitment to a fixed skill set. But biotech needs are fluid. One month you need rigorous data review and the next, you need on-site assay troubleshooting.
Why Pointer Bio?
We offer an on-demand scientific department. By choosing a partner over a permanent hire, you gain:
Instant Seniority: No recruiting cycles or onboarding lags.
Capital Efficiency: You pay for expert output, not desk time.
Scalability: We ramp up during critical study phases and scale back when the work is in the CRO’s hands.
Great science shouldn't be held back by the constraints of a traditional org chart. Your next hire shouldn’t be a person, it should be a partnership.
